🏥 Health 1d ago

Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos

MedPage Today
Medical news for professionals
View Channel →
Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos
Source ↗ 👁 1 💬 0
(MedPage Today) -- Xenon Pharmaceuticals said it paused enrollment in its major depressive disorder and bipolar depression trials after unexpected neuropsychiatric adverse events emerged.
Many mental health and suicide risk indicators among youth...

Comments (0)

Sign in to join the discussion

More Like This

📰
More REM sleep linked to lower risk of 83 diseases
Health & Medicine News -- ScienceDaily · 1d ago
📰
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Health & Medicine News -- ScienceDaily · 1d ago
White House plan to increase control of NIH grants appears ‘dead’
STAT · 1d ago
Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration
MedPageToday.com - medical news for physicians · 1d ago
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
STAT · 1d ago
📰
Gifts from Friends provides thoughtful way to celebrate
Vanderbilt Health News · 1d ago